Sign inGet started

Shaffer James P

Insider CIK 1488919 · HALO VP & Chief Commercial Officer · EIGR Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EIGR Eiger BioPharmaceuticals, A Award deriv2021-03-122021-03-1571,250— $071,250SEC↗
EIGR Eiger BioPharmaceuticals, A Award2021-03-122021-03-1511,875— $029,296SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2020-03-122020-03-1350,000— $050,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2020-03-052020-03-131,500$7.31 $11.0K15,921SEC↗
EIGR Eiger BioPharmaceuticals, A Award2019-09-052019-09-061,500$7.95 $11.9K14,421SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2019-03-212019-03-2650,000— $050,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2019-03-052019-03-261,500$7.95 $11.9K12,921SEC↗
EIGR Eiger BioPharmaceuticals, A Award2018-09-052019-03-261,500$7.95 $11.9K11,421SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2018-03-142018-03-1660,000— $060,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2018-03-052019-03-261,500$8.03 $12.0K9,921SEC↗
EIGR Eiger BioPharmaceuticals, A Award2017-09-052019-03-261,500$9.90 $14.8K8,421SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2017-03-092017-03-1440,000— $040,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award2017-03-062019-03-261,301$8.20 $10.7K6,921SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2016-08-182016-08-193,125$15.70 $49.1K5,620SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2016-06-132016-06-14420$22.20 $9.3K2,495SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2016-06-132016-06-14730$22.16 $16.2K1,975SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2016-06-132016-06-14100$22.17 $2.2K2,075SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2016-05-232016-05-23745$19.99 $14.9K1,245SEC↗
EIGR Eiger BioPharmaceuticals, P Buy2016-05-192016-05-23500$19.52 $9.8K500SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2016-03-232016-09-1560,699— $060,699SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2016-03-232016-03-2860,699— $060,699SEC↗
HALO HALOZYME THERAPEUTICS INC A Award deriv2014-02-062014-02-1031,500— $031,500SEC↗
HALO HALOZYME THERAPEUTICS INC A Award deriv2014-02-062014-02-1050,000$13.10 $655.0K50,000SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise deriv2014-02-042014-02-047,500— $022,500SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise2014-02-042014-02-044,864— $054,025SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise deriv2014-02-022014-02-0416,204— $048,612SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise deriv2014-02-022014-02-042,084— $04,166SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise2014-02-022014-02-041,242— $049,161SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise2014-02-022014-02-0410,387— $047,919SEC↗
HALO HALOZYME THERAPEUTICS INC A Award deriv2013-02-042013-02-0630,000— $030,000SEC↗
HALO HALOZYME THERAPEUTICS INC A Award deriv2013-02-042013-02-0650,000$6.55 $327.5K50,000SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise2013-02-022013-02-059,993— $036,293SEC↗
HALO HALOZYME THERAPEUTICS INC M Exercise2013-02-022013-02-051,239— $037,532SEC↗
HALO HALOZYME THERAPEUTICS INC P Buy2012-11-142012-11-1420,000$5.22 $104.4K26,300SEC↗
HALO HALOZYME THERAPEUTICS INC A Award deriv2012-02-022012-02-0681,019— $089,353SEC↗
HALO HALOZYME THERAPEUTICS INC A Award deriv2012-02-022012-02-068,334— $08,334SEC↗
HALO HALOZYME THERAPEUTICS INC A Award deriv2012-02-022012-02-0616,667$11.29 $188.2K16,667SEC↗